Suchergebnisse - "Nakao, Masamitsu"

PubPharm (58)

1

Portal venous blood flows determine liver function in patients with decompensated cirrhosis due to HCV infection receiving successful sofosbuvir/velpatasvir therapy

enthalten in: ResearchSquare.com | 2023

von Uchida, Y. | Imai, Y. | Tsuji, S. | +10

2

Significance of portal venous blood flow as a factor to determine liver function in patients with decompensated cirrhosis due to hepatitis C virus infection following achievement of sustained viral response by sofosbuvir plus velpatasvir

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2023

von Uchida, Y. | Imai, Y. | Tsuji, S. | +10

3

Significance of portal venous blood flow as a factor to determine liver function in patients with decompensated cirrhosis due to hepatitis C virus infection following achievement of sustained viral response by sofosbuvir plus velpatasvir

enthalten in: Hepatology Research | 2023

von Uchida, Y. | Imai, Y. | Tsuji, S. | +10

4

Significance of furosemide in patients with cirrhosis treated with or without zinc acetate hydrate supplementation

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2022

von Uchida, Y. | Uemura, H. | Tsuji, S. | +9

5

Superiority of tenofovir alafenamide fumarate over entecavir for serum HBsAg level reduction in patients with chronic HBV infection : A 144-week outcome study after switching of the nucleos(t)ide analog

enthalten in: PloS one | 2022

von Uchida, Y. | Nakao, M. | Yamada, S. | +9

6

Significance of furosemide in patients with cirrhosis treated with or without zinc acetate hydrate supplementation

enthalten in: Hepatology Research | 2022

von Uchida, Y. | Uemura, H. | Tsuji, S. | +9

7

Furosemide as a factor to deteriorate therapeutic efficacy of tolvaptan in patients with decompensated cirrhosis

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2020

von Uchida, Y. | Inao, M. | Tsuji, S. | +9

8

Furosemide as a factor to deteriorate therapeutic efficacy of rifaximin in patients with decompensated cirrhosis

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2020

von Uchida, Y. | Tsuji, S. | Uemura, H. | +9

9

Significance of switching of the nucleos(t)ide analog used to treat Japanese patients with chronic hepatitis B virus infection from entecavir to tenofovir alafenamide fumarate

enthalten in: Journal of medical virology | 2020

von Uchida, Y. | Nakao, M. | Tsuji, S. | +9

ErratumFor: J Med Virol. 2020 Mar;92(3):329-338. - PMID 31777965

10

Involvement of portosystemic shunts in impaired improvement of liver function after direct-acting antiviral therapies in cirrhotic patients with hepatitis C virus

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2020

von Tsuji, S. | Uchida, Y. | Uemura, H. | +9

1
2
3
4
5
6
Nächster »
[6]